<?xml version="1.0" encoding="UTF-8"?>
<p>Primary infection with DENV induces potent innate immune responses, which will exert direct antiviral activities and also shape humoral (antibody production by B cells) and cellular (mediated by CD4+ and CD8+ T cells) responses that can be either DENV serotype-specific or cross-reactive against different serotypes (for reviews see [
 <xref rid="B1-vaccines-08-00174" ref-type="bibr">1</xref>,
 <xref rid="B2-vaccines-08-00174" ref-type="bibr">2</xref>,
 <xref rid="B3-vaccines-08-00174" ref-type="bibr">3</xref>]).
</p>
